Skip to main content
. 2020 Oct 31;3(1):vdaa146. doi: 10.1093/noajnl/vdaa146

Figure 2.

Figure 2.

The application for GBM survival prediction using the survival-predictive nomogram. A representative clinical example is shown in which a 43-year-old GBM patient with a KPS score of 70 had an IDH1-mutant tumor. This patient had a 2%, 72%, and 26% chance of being a short-term survivor (<6 months), long-term survivor (>5 years), and median-term survivor (~15 months), respectively. Two percent of patients had this outcome.